BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34438446)

  • 1. Physiologic IGFBP7 levels prolong IGF1R activation in acute lymphoblastic leukemia.
    Artico LL; Laranjeira ABA; Campos LW; Corrêa JR; Zenatti PP; Carvalheira JBC; Brambilla SR; Nowill AE; Brandalise SR; Yunes JA
    Blood Adv; 2021 Sep; 5(18):3633-3646. PubMed ID: 34438446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGFBP7 Fuels the Glycolytic Metabolism in B-Cell Precursor Acute Lymphoblastic Leukemia by Sustaining Activation of the IGF1R-Akt-GLUT1 Axis.
    Artico LL; Ruas JS; Teixeira Júnior JR; Migita NA; Seguchi G; Shi X; Brandalise SR; Castilho RF; Yunes JA
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors.
    Evdokimova V; Tognon CE; Benatar T; Yang W; Krutikov K; Pollak M; Sorensen PH; Seth A
    Sci Signal; 2012 Dec; 5(255):ra92. PubMed ID: 23250396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation.
    Tian D; Mitchell I; Kreeger PK
    BMC Syst Biol; 2016 Feb; 10():15. PubMed ID: 26861122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
    Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival.
    Verhagen HJ; de Leeuw DC; Roemer MG; Denkers F; Pouwels W; Rutten A; Celie PH; Ossenkoppele GJ; Schuurhuis GJ; Smit L
    Cell Death Dis; 2014 Jun; 5(6):e1300. PubMed ID: 24967962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.
    Kashyap MK
    Tumour Biol; 2015 Nov; 36(11):8247-57. PubMed ID: 26369544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase.
    Laranjeira AB; de Vasconcellos JF; Sodek L; Spago MC; Fornazim MC; Tone LG; Brandalise SR; Nowill AE; Yunes JA
    Leukemia; 2012 May; 26(5):1001-11. PubMed ID: 22005787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.
    Bartram I; Erben U; Ortiz-Tanchez J; Blunert K; Schlee C; Neumann M; Heesch S; Baldus CD
    BMC Cancer; 2015 Oct; 15():663. PubMed ID: 26450156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor binding protein production in bovine retinal endothelial cells.
    Giannini S; Cresci B; Manuelli C; Fujita-Yamaguchi Y; Romagnani P; Mohan S; Rotella CM
    Metabolism; 1997 Dec; 46(12):1367-79. PubMed ID: 9439529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ; Yenson VM; Baxter RC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy.
    Tian D; Kreeger PK
    BMC Syst Biol; 2014 Aug; 8():98. PubMed ID: 25115504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.
    Fujita M; Ieguchi K; Cedano-Prieto DM; Fong A; Wilkerson C; Chen JQ; Wu M; Lo SH; Cheung AT; Wilson MD; Cardiff RD; Borowsky AD; Takada YK; Takada Y
    J Biol Chem; 2013 Jul; 288(27):19593-603. PubMed ID: 23696648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression levels of mRNA for insulin-like growth factors 1 and 2, IGF receptors and IGF binding proteins in in vivo and in vitro grown bovine follicles.
    Rebouças EL; Costa JJ; Passos MJ; Silva AW; Rossi RO; van den Hurk R; Silva JR
    Zygote; 2014 Nov; 22(4):521-32. PubMed ID: 23659735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
    Sarfstein R; Nagaraj K; LeRoith D; Werner H
    Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation.
    Yang Q; Zang HM; Xing T; Zhang SF; Li C; Zhang Y; Dong YH; Hu XW; Yu JT; Wen JG; Jin J; Li J; Zhao R; Ma TT; Meng XM
    Phytomedicine; 2021 May; 85():153541. PubMed ID: 33773190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proximity-labeling technique BioID identifies sorting nexin 6 as a member of the insulin-like growth factor 1 (IGF1)-IGF1 receptor pathway.
    Bareja A; Hodgkinson CP; Soderblom E; Waitt G; Dzau VJ
    J Biol Chem; 2018 Apr; 293(17):6449-6459. PubMed ID: 29530981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.
    Stanley TL; Fourman LT; Zheng I; McClure CM; Feldpausch MN; Torriani M; Corey KE; Chung RT; Lee H; Kleiner DE; Hadigan CM; Grinspoon SK
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e520-e533. PubMed ID: 33125080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.